Menu
Currency
GWAS Study

Genome-wide investigation of persistence to treatment with methotrexate in early rheumatoid arthritis.

Sysojev AÖ, Saevarsdottir S, Diaz-Gallo LM et al.

37326842 PubMed ID
GWAS Study Type
3260 Participants
47 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SA
Sysojev AÖ
SS
Saevarsdottir S
DL
Diaz-Gallo LM
SG
Silberberg GN
AL
Alfredsson L
KL
Klareskog L
BE
Baecklund E
BL
Björkman L
KA
Kastbom A
RS
Rantapää-Dahlqvist S
TC
Turesson C
JI
Jonsdottir I
SK
Stefansson K
FT
Frisell T
PL
Padyukov L
AJ
Askling J
WH
Westerlind H
Chapter II

Abstract

Summary of the research findings

Objectives: To investigate the influence of genetic factors on persistence with treatment of early RA with MTX monotherapy.

2,112 Swedish ancestry cases, 1,148 Swedish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

3260
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Sweden
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.